WAYFINDER trial of tezepelumab monthly injection shows oral steroid reduction for most severe asthma
The international WAYFINDER trial – led by King’s College London – has shown that for severe asthma patients the use of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback